Property, Plant and Equipment, Net of CANNAPHARMARX, INC. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary: CANNAPHARMARX, INC. quarterly Property, Plant and Equipment, Net in USD history and change rate from 31 Dec 2013 to 30 Sep 2025.
CANNAPHARMARX, INC. Property, Plant and Equipment, Net for the quarter ending 30 Sep 2025 was $123,333, a 20% decline year-over-year.
Source SEC data: View on sec.gov

Property, Plant and Equipment, Net, Quarterly (USD)

Property, Plant and Equipment, Net, YoY Quarterly Change (%)

CANNAPHARMARX, INC. Quarterly Property, Plant and Equipment, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$123,333	-$30,710	-20%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$129,389			30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	$130,077	-$20,124	-13%	31 Mar 2025	10-Q	16 May 2025	2025	Q1
Q4 2024	$137,237	-$24,303	-15%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q3 2024	$154,043	-$13,440	-8%	30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q1 2024	$150,201	+$47,353	+46%	31 Mar 2024	10-Q	25 Jun 2024	2024	Q1
Q4 2023	$161,540	+$53,760	+50%	31 Dec 2023	10-K	10 Apr 2025	2024	FY
Q3 2023	$167,483	+$61,868	+59%	30 Sep 2023	10-Q	17 Nov 2023	2023	Q3
Q2 2023	$173,032	+$55,729	+48%	30 Jun 2023	10-Q	13 Oct 2023	2023	Q2
Q1 2023	$102,848	+$81,092	+373%	31 Mar 2023	10-Q	22 Sep 2023	2023	Q1
Q4 2022	$107,780	+$101,748	+1687%	31 Dec 2022	10-Q	17 Nov 2023	2023	Q3
Q3 2022	$105,615	+$98,860	+1464%	30 Sep 2022	10-Q	21 Nov 2022	2022	Q3
Q2 2022	$117,303	-$1,499,408	-93%	30 Jun 2022	10-Q	22 Aug 2022	2022	Q2
Q1 2022	$21,756	-$1,572,472	-99%	31 Mar 2022	10-Q	23 May 2022	2022	Q1
Q4 2021	$6,032	-$1,562,719	-100%	31 Dec 2021	10-K	01 Sep 2023	2022	FY
Q3 2021	$6,755	-$1,630,521	-100%	30 Sep 2021	10-Q	15 Nov 2021	2021	Q3
Q2 2021	$1,616,711	+$13,780	+0.86%	30 Jun 2021	10-Q	16 Aug 2021	2021	Q2
Q1 2021	$1,594,228	+$54,064	+3.5%	31 Mar 2021	10-Q	17 May 2021	2021	Q1
Q4 2020	$1,568,751	+$27,833	+1.8%	31 Dec 2020	10-K	15 Apr 2022	2021	FY
Q3 2020	$1,637,276			30 Sep 2020	10-Q	12 Nov 2020	2020	Q3
Q2 2020	$1,602,931			30 Jun 2020	10-Q	19 Aug 2020	2020	Q2
Q1 2020	$1,540,164			31 Mar 2020	10-Q	29 Jun 2020	2020	Q1
Q4 2019	$1,540,918	-$147,179	-8.7%	31 Dec 2019	10-K	14 Apr 2021	2020	FY
Q4 2018	$1,688,097	+$1,688,097		31 Dec 2018	10-K	27 May 2020	2019	FY
Q3 2018	$0	$0		30 Sep 2018	10-Q	13 Nov 2018	2018	Q3
Q2 2018	$0	$0		30 Jun 2018	10-Q	14 Sep 2018	2018	Q2
Q1 2018	$0	$0		31 Mar 2018	10-Q	14 Sep 2018	2018	Q1
Q4 2017	$0	$0		31 Dec 2017	10-Q	13 Nov 2018	2018	Q3
Q3 2017	$0			30 Sep 2017	10-Q	14 Sep 2018	2017	Q3
Q2 2017	$0			30 Jun 2017	10-Q	14 Sep 2018	2017	Q2
Q1 2017	$0			31 Mar 2017	10-Q	14 Sep 2018	2017	Q1
Q4 2016	$0	$0		31 Dec 2016	10-K	14 Sep 2018	2017	FY
Q4 2015	$0	-$97,701	-100%	31 Dec 2015	10-Q	14 Sep 2018	2016	Q1
Q3 2015	$90,259	+$77,920	+631%	30 Sep 2015	10-Q	13 Nov 2015	2015	Q3
Q2 2015	$93,452			30 Jun 2015	10-Q	12 Aug 2015	2015	Q2
Q1 2015	$96,644			31 Mar 2015	10-Q	14 May 2015	2015	Q1
Q4 2014	$97,701	+$97,701		31 Dec 2014	10-K	11 Sep 2018	2015	FY
Q3 2014	$12,339			30 Sep 2014	10-Q	19 Nov 2014	2014	Q3
Q4 2013	$0			31 Dec 2013	10-K	31 Mar 2015	2014	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.